The PALS Study: Picturing Aeration with Lung Ultrasound after Surfactant

Not Applicable

Not yet recruiting

• Conditions: neonatal respiratory distress syndrome; neonatal respiratory distress; Respiratory - Other respiratory disorders / diseases; Reproductive Health and Childbirth - Complications of newborn; prematurity

• Registration Number: ACTRN12621001758897
• Lead Sponsor: Monash Medical Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-23
• Last Update Posted: 27 December 2021

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Infants less than or equal to 72 hours old receiving their first dose of surfactant are eligible for this study

Exclusion Criteria

Infants will be excluded if they have a congenital abnormality that affects the lungs, like congenital diaphragmatic hernia. We will also exclude the infants of parents who cannot speak English (as verbal consent cannot be obtained).

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in lung ultrasound grade when comparing lung ultrasound video recordings before and after surfactant administration). [Within 5 minutes after surfactant administration ]

Secondary Outcome Measures

Name	Time	Method
<br>Change in lung ultrasound grade when comparing lung ultrasound video recordings before and after surfactant administration). [10-20 minutes after surfactant administration, 1-2 hours after surfactant administration. ]